Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 15;12(9):1164.
doi: 10.3390/pathogens12091164.

One Health Spread of 16S Ribosomal RNA Methyltransferase-Harboring Gram-Negative Bacterial Genomes: An Overview of the Americas

Affiliations

One Health Spread of 16S Ribosomal RNA Methyltransferase-Harboring Gram-Negative Bacterial Genomes: An Overview of the Americas

Fábio Parra Sellera et al. Pathogens. .

Abstract

Aminoglycoside antimicrobials remain valuable therapeutic options, but their effectiveness has been threatened by the production of bacterial 16S ribosomal RNA methyltransferases (16S-RMTases). In this study, we evaluated the genomic epidemiology of 16S-RMTase genes among Gram-negative bacteria circulating in the American continent. A total of 4877 16S-RMTase sequences were identified mainly in Enterobacterales and nonfermenting Gram-negative bacilli isolated from humans, animals, foods, and the environment during 1931-2023. Most of the sequences identified were found in the United States, Brazil, Canada, and Mexico, and the prevalence of 16S-RMTase genes have increased in the last five years (2018-2022). The three species most frequently carrying 16S-RMTase genes were Acinetobacter baummannii, Klebsiella pneumoniae, and Escherichia coli. The armA gene was the most prevalent, but other 16S-RMTase genes (e.g., rmtB, rmtE, and rmtF) could be emerging backstage. More than 90% of 16S-RMTase sequences in the Americas were found in North American countries, and although the 16S-RMTase genes were less prevalent in Central and South American countries, these findings may be underestimations due to limited genomic data. Therefore, whole-genome sequence-based studies focusing on aminoglycoside resistance using a One Health approach in low- and middle-income countries should be encouraged.

Keywords: 16S-RMTase; Acinetobacter baumannii; Enterobacterales; One Health; Pseudomonas aeruginosa; aminoglycoside resistance; armA; rmtB; rmtF.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Temporal distribution of 16S-RMTase genes during 2000–2022 in the Americas.
Figure 2
Figure 2
Geographical distribution of 16S-RMTase-harboring bacterial genomes from 1931 to June 2023 in the Americas. Colored countries show quantity of 16S-RMTase-harboring bacterial genomes found. Circle charts show the presence of the 16S-RMTase types present in each country. Sources of origins were grouped into human, animal, food, or environmental samples.

Similar articles

Cited by

References

    1. Murray C.J.L., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed
    1. Uddin T.M., Chakraborty A.J., Khusro A., Zidan B.R.M., Mitra S., Bin Emran T., Dhama K., Ripon K.H., Gajdács M., Sahibzada M.U.K., et al. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J. Infect. Public Heal. 2021;14:1750–1766. doi: 10.1016/j.jiph.2021.10.020. - DOI - PubMed
    1. Fuga B., Sellera F.P., Cerdeira L., Esposito F., Cardoso B., Fontana H., Moura Q., Cardenas-Arias A., Sano E., Ribas R.M., et al. WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil. Microbiol. Spectr. 2022;10:e0125621. doi: 10.1128/spectrum.01256-21. - DOI - PMC - PubMed
    1. Kotra L.P., Haddad J., Mobashery S. Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance. Antimicrob. Agents Chemother. 2000;44:3249–3256. doi: 10.1128/AAC.44.12.3249-3256.2000. - DOI - PMC - PubMed
    1. Vakulenko S.B., Mobashery S. Versatility of Aminoglycosides and Prospects for Their Future. Clin. Microbiol. Rev. 2003;16:430–450. doi: 10.1128/CMR.16.3.430-450.2003. - DOI - PMC - PubMed

LinkOut - more resources